# A Study of ASP1941 in Japanese Patients With Type 2 Diabetes Mellitus

> **NCT01023945** · PHASE1 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 30 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** ASP1941
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01023945
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11-07
- **Primary completion:** 2010-03-26
- **Final completion:** 2010-03-26
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2024-11-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01023945

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01023945, "A Study of ASP1941 in Japanese Patients With Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01023945. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*